Skip to main content

Table 2 Chemotherapeutic agents used

From: Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance

Chemotherapy regimen

No. of subjects

Cyclophosphamide, thalidomide, dexamethasone

4

Cyclophosphamide, thalidomide, dexamethasone/prednisone

1

Bortezomib, dexamethasone, cyclophosphamide

2

Cyclophosphamide, prednisone/mesna

1

Cyclophosphamide, prednisone

2

Cyclophosphamide, prednisone/dexamethasone

1

Cyclophosphamide, dexamethasone, vindesine, epirubicin

1

Cyclophosphamide, dexamethasone

1

Thalidomide, dexamethasone

1

Bortezomib, prednisone

1

None

17